Gene Query: COPZ1

Dataset Description Geneva Score
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 39.66
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 37.88
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 37.88
NRDE2 negatively regulates nuclear exosome functions 29.08
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 28.76
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 26.61
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 24.1
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 23.03
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 22.95
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 22.14
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 21.47
Mapping interactions for the TNIP2 hub protein 20.49
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 19.52
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 19.45
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 19.34
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 18.51
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 18.33
Effect of Influenza virus infection on lncRNA expression in A549 cells 17.91
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 17.6
An RNA-centric dissection of host complexes controlling flavivirus infection 17.6
The regulartory role of ZCCHC24 in splicing machinery 17.01
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 16.99
3’ Uridylation Expands miRNA Target Repertoire 16.96
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 16.86
Sensing self and nonself circular RNAs 16.76
RNA-sequencing of human liver tissue 16.72
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 16.5
HNRNPL and its RNA Targets in Prostate Cancer 16.39
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 16.39
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 15.63
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 15.41
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 15.25
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 15.15
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 14.78
Lipid degradation promotes prostate cancer cell survival 14.37
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 14.35
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 14.35
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 13.97
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 13.95
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 13.79
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 13.69
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 13.68
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 13.57
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 13.51
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 13.28
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 13.23
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 13.09
LncRNA expression profiling of ischemic stroke patients 13.06
Genome wide expression change in LCC2 and MCF-7 cells 12.8
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 12.58
ARS2 is a general suppressor of pervasive transcription [RNAseq] 12.4
Stem and effector CD8 T-cells from human cancers 12.29
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 12.24
Next generation sequencing of small RNAs isolated from exosomes in human semen 12.11
hnRNP C is a key regulator of protein synthesis in mitosis 12.11
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 11.98
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 11.84
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 11.84
The human blood-nerve barrier transcriptome 11.28
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 10.8
Microprocessor mediates transcription termination in long noncoding microRNA genes 10.79
Transcriptomic analysis of the HOTAIR-regulated genes 10.74
U1 snRNP telescripting regulates size-function stratified human genome 10.67
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 10.52
CD73 knockdown effect in pancreatic cancer cell lines 10.48
T47D RNA-seq and ChrRNA-seq data 10.48
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 10.48
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 10.44
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 10.42
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 10.42
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 10.22
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 10.2
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 10.14
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 9.95
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 9.84
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 9.74
RNA transcriptome analysis during HSV-1 infection 9.73
SLIGRL-induced gene expression changes in NHEK cells 9.64
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 9.63
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 9.58
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 9.58
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 9.46
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 9.37
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 9.33
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 9.29
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 9.29
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 9.25
scRNASeq analysis of cycling cardiomyocytes 9.18
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 9.17
Solid phase chemistry to covalently and reversibly capture thiolated RNA 9.14
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 9.12
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 9.12
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 9.11
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 9.09
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 9.07
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 9.07
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 9.0
RNA-seq of YB5 cells treated with Proscillaridin A 8.99
Transcriptomic analysis of human tonsillar TFH subsets 8.98
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 8.95
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 8.95
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 8.95
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 8.94
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 8.91
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 8.91
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 8.87
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 8.87
Identification of Atrial Fibrillation associated genes and functional non-coding variants 8.86
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.84
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 8.77
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 8.63
RIG-I and MDA5 fRIP during KSHV lytic reactivation 8.62
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 8.61
Region-specific Innate Antiviral Responses of the Human Epididymis 8.52
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 8.48
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 8.46
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 8.38
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 8.36
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 8.3
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 8.27
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 8.23
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 8.23
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 8.23
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 8.22
Global analysis of enhancer targets: Mosaic-seq 8.19
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 8.19
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 8.19
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 8.18
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 8.18
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 8.18
CROP-Seq in Primary Human T Cells 8.16
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 8.13
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 8.12
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 8.11
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 8.09
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 8.09
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 8.06
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.01
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 8.01
Transcriptomic analyssis following EHMT1/2 inhibition 8.0
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 7.91
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 7.91
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 7.87
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.85
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 7.72
RNA-sequencing of formalin fixed human primary melanoma tissue 7.68
An optimization system for isolating and sequencing of single human colon cancer cells 7.66
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 7.61
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 7.61
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 7.56
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 7.55
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 7.55
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 7.46
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 7.46
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 7.43
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 7.4
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 7.36
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 7.36
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.3
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 7.28
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 7.28
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 7.28
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.27
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 7.26
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 7.11
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 7.1
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 7.04
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 7.01
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 6.99
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 6.99
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 6.97
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 6.93
Role of XRN2 ribonucleolytic activity in RNA metabolism 6.93
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 6.9
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 6.89
Exploring the RNA landscape of endothelial exosomes 6.87
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 6.79
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 6.74
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 6.73
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 6.73
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 6.71
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 6.7
The pause-initiation limit restricts transcription activation in human cells 6.63
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 6.63
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 6.61
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 6.61
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 6.58
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 6.57
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 6.54
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 6.51
MYC dependent mRNA translation shapes gene expression and cell biology 6.45
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 6.4
The comparison of high-throughput single-cell RNA-seq methods 6.34
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 6.32
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 6.29
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 6.27
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 6.26
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 6.16
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 6.16
Differetially expressed genes after hTR overexpression in U2OS cells 6.15
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 6.14
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 6.11
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 6.11
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 6.06
Role of microRNAs in the interaction between Salmonella and the host cell 6.04
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 5.96
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 5.94
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 5.94
An integrative analysis of non-coding regulatory DNA variations associated with autism 5.92
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 5.88
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 5.83
RNA m5C Methylation in breast cancer using MeRIP-Seq 5.82
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 5.75
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 5.73
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 5.73
Morphological and molecular characterization of human dermal lymphatic collectors 5.68
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 5.63
Activity-dependent transcriptional changes in human neurons 5.6
Profiling of escape kinetics of viruses subjected to RNAi 5.59
RNA-seq analysis of the human fetal kidney. 5.58
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 5.56
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 5.52
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 5.47
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 5.45
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 5.43
Single-cell analysis of adult human ovary using 10X genomics 5.4
Differential Protein Occupancy Profiling of the mRNA Transcriptome 5.35
RNA-sequencing in irradiated and normal A549 cells. 5.32
Iron response of HepG2 cells 5.3
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 5.24
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 5.24
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 5.23
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 5.22
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 5.19
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 5.16
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 5.13
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 5.12
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 5.1
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 5.07
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.01
K562 polyA RNA-Seq 5.01
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 5.0
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 4.92
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 4.92
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 4.91
Widespread intronic polyadenylation diversifies immune cell transcriptomes 4.89
single cell RNA-seq from GM12878 (ENCSR673UIY) 4.88
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.88
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 4.84
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 4.8
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 4.8
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 4.77
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 4.77
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.77
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.77
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.77
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 4.7
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 4.7
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 4.67
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 4.66
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 4.66
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.62
METTL3 and WTAP 4.61
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 4.59
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 4.51
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.49
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 4.47
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 4.46
Global analyses of the effect of different cellular contexts on microRNA targeting 4.46
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 4.44
RNA editing in nascent RNA affects pre-mRNA splicing 4.43
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 4.41
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 4.39
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 4.38
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 4.37
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 4.34
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 4.33
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 4.29
Transcription elongation regulates genome 3D structure 4.28
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 4.15
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.13
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.13
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 4.12
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.07
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 4.06
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 4.06
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 4.03
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 3.99
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 3.91
Differential gene expression profiles in imatinib-resistant cell lines 3.9
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 3.86
Dynamic 3D chromosomal landscapes in acute leukemia 3.79
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 3.79
Effect of FGF13 depletion on the H460 cell line 3.76
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 3.76
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 3.66
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 3.66
ADAR1-editing of cellular and measles virus-derived duplex RNA 3.65
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 3.65
RNA-seq of RKO cells with cTAZ KO or putback 3.6
Loss of CREBBP results in gene expression repression in lymphoma cells 3.58
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.58
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.54
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.53
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 3.53
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 3.46
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 3.46
Systematic discovery of endogenous human ribonucleoprotein complexes 3.4
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 3.39
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.36
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 3.25
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 3.22
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 3.22
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.16
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 3.15
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 3.14
High-throughput sequencing of PROMPT-enriched samples. 3.14
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.12
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 3.1
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.04
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.04
Positively selected enhancer elements endow tumor cells with metastatic competence 3.03
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 3.0
Toxoplasma gondii infection of human retinal pigment epithelial cells 2.98
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 2.98
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 2.97
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 2.97
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 2.95
MAIT cell RNA sequencing 2.93
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 2.91
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.86
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 2.85
CDK12 mediated transcriptional regulation in U2OS cells 2.85
NAPRT activation of macrophages 2.84
RNA Sequencing of Human iPS derived Cardiomyocytes 2.72
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 2.68
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 2.67
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 2.66
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 2.62
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 2.62
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 2.6
MicroRNA-125a-5p overexpression in human macrophages 2.56
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 2.53
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 2.52
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 2.51
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 2.51
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 2.44
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 2.44
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 2.41
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 2.4
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.39
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.37
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 2.35
Tracking distinct RNA populations using efficient and reversible covalent chemistry 2.35
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.35
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 2.31
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.29
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.25
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 2.23
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 2.23
Global transcriptome analysis of WT versus HEB-/- hESCs 2.22
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.21
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.2
Induced DNA demethylation, genome instability and transcription 2.18
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 2.18
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 2.14
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 2.14
Determining mRNA half-lives on a transcriptome-wide scale 2.13
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 2.1
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 2.08
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.08
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 2.04
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.02
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 2.02
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 2.02
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.99
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 1.98
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 1.98
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.97
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.97
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.96
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 1.9
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.86
mRNA expression in human DAOY cells 1.85
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 1.84
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.83
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 1.79
Transposon-based construction of strand-specific RNA-seq libraries 1.78
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.78
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.69
Gene expression analysis of human adenomas. 1.68
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.67
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.66
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 1.65
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 1.61
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.57
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.56
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.56
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.56
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.52
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.52
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.52
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 1.48
An siRNA screen identifies CHD4 as a target for epigenetic therapy 1.46
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.46
p53 activity results in DNA replication fork processivity 1.44
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 1.44
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.44
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.43
Genome-wide identification of cancer-specific alternative splicing in circRNA 1.42
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.4
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.4
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.39
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 1.38
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.35
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 1.34
Transcriptional landscape changes during human embryonic stem cell derivation 1.33
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 1.28
RNA seq_PDX2_SHP099 1.27
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.21
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.21
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 1.19
Cleavage Factor Im as a key regulator of 3’ UTR length 1.16
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.13
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.12
Enhancer activation during EGF response 1.1
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.09
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.09
Comparative Analysis of Cas9 Activators Across Multiple Species 1.07
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.05
Effect of BMP inhibition or stimulation of primary human keratinocytes 0.98
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 0.98
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.96
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 0.95
HBEC-shp53-PCHD7 0.93
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.93
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.92
siRNA-mediated knockdown 0.92
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.91
6mer seed toxicity in viral microRNAs 0.87
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.85
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.81
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.78
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.76
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.76
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.74
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 0.73
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.72
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.69
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.67
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 0.66
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.65
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.65
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 0.65
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.62
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 0.59
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 0.59
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 0.59
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.58
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.58
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.57
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.52
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.52
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.51
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 0.5
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.46
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.46
Oncogenic roles of ARID5B in T-ALL 0.46
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.43
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.42
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 0.41
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.39
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.39
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.37
High-resolution comparative analysis of great ape genomes 0.31
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.27
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.27
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.26
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.22
Myc activation coordinates gene transcription and protein translation responses 0.21
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.19
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.19
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.19
Zika virus directly infects human peripheral neurons and induces cell death 0.17
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.14
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.12
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.12
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.11
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.09
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.09
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.09
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.08
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.07
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.06
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.05
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.03
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.03
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.03
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.02
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation